IOVA IOVANCE BIOTHERAPEUTICS, INC.: institutional ownership and insider trading
316 funds reported holding $1.35B of IOVANCE BIOTHERAPEUTICS, INC. in their latest 13F filings; in Q2 2026 funds net bought $81.2M, with 40 new positions and 37 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market; over its last four quarters it reported revenue of $325M and net income of −$290M.
IOVA revenue and earnings
- Quarter ended Jun 30, 2026: revenue $99.3M, net income −$47.3M, EPS -0.11
- Quarter ended Mar 31, 2026: revenue $71.4M, net income −$79.0M, EPS -0.19
- Quarter ended Dec 31, 2025: revenue $86.8M, net income −$71.9M
- Quarter ended Sep 30, 2025: revenue $67.5M, net income −$91.3M
Famous investors holding IOVA
- Two Sigma (Two Sigma Investments): $79.1M, 0.1% of the portfolio
- Izzy Englander (Millennium Management): $35.5M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $15.1M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $8.92M, 0.0% of the portfolio
Largest institutional holders of IOVA
- BlackRock, Inc. (BLK) — $154M
- MHR FUND MANAGEMENT LLC — $121M
- STATE STREET CORP (STT, STT-PG) — $102M
- TWO SIGMA INVESTMENTS, LP — $79.1M
- VANGUARD CAPITAL MANAGEMENT LLC — $75.7M
- VANGUARD GROUP INC — $74.3M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $59.9M
- GEODE CAPITAL MANAGEMENT, LLC — $43.0M
- MILLENNIUM MANAGEMENT LLC — $35.5M
- SUSQUEHANNA INTERNATIONAL GROUP, LLP — $32.1M
Recent IOVA insider trades
- Jun 5, 2025: Kirby Daniel Gordon bought 30,000 shares ($55.2K)
- May 23, 2025: Puri Raj K. bought 5,600 shares ($9.74K)
- May 14, 2025: Vogt Frederick G bought 25,000 shares ($42.3K)
- Nov 12, 2024: Maynard Ryan D sold 50,000 shares ($503K)
5%+ owners
- BlackRock, Inc.: 7.5% (Schedule 13G/A, filed Jul 28, 2026)
- STATE STREET CORPORATION: 5.5% (Schedule 13G, filed Aug 7, 2026)
Who owns the most IOVA stock?
The largest institutional holders of IOVANCE BIOTHERAPEUTICS, INC. in the latest 13F filings are BlackRock, Inc. (BLK) ($154M), MHR FUND MANAGEMENT LLC ($121M), STATE STREET CORP (STT, STT-PG) ($102M).
Are insiders buying or selling IOVA?
No open-market insider buys or sells of IOVANCE BIOTHERAPEUTICS, INC. were reported in the last 12 months.
Which famous investors own IOVA?
Two Sigma, Izzy Englander, Ken Griffin, D. E. Shaw.
What was IOVA's revenue last quarter?
IOVANCE BIOTHERAPEUTICS, INC. reported revenue of $99.3M for the quarter ended June 30, 2026, with net income of −$47.3M.
Which ETFs hold IOVA?
10 ETFs and mutual funds hold it among their top 100 positions, including XBI, IDNA, BIVIX, LABU.